Novartis | Des Atouts

Name: Novartis | Des Atouts
Creator: TRADING ECONOMICS
License: https://creativecommons.org/licenses/by/4.0/

width

height

	Assets		Date
Alcon AG ALC:SW	26.48B	1.31B	2022-06
Amgen AMGN:US	$ 59294M	98M	2022-06
AstraZeneca AZN:LN	96579M	3694M	2022-06
Bayer BAYN:GR	€ 128794M	3012M	2022-06
Biogen BIIB:US	$ 25081.4M	1467M	2022-06
Bristol Myers Squibb BMY:US	$ 100357M	2677M	2022-06
Eli Lilly And LLY:US	$ 47063.6M	144.3M	2022-06
Fresenius FRE:GR	€ 76112M	2998M	2022-06
Fresenius Medical Care FME:GR	€ 36070M	1345.87M	2022-06
Galapagos GLPG:NA	€ 5040.08M	60.23M	2022-06
Genmab GEN:DC	DK 27476M	2562M	2022-06
Gilead Sciences GILD:US	$ 62870M	210M	2022-06
GlaxoSmithKline GSK:LN	89045M	644M	2022-06
Hikma Pharmaceutical HIK:LN	4.75B	375M	2022-06
Lonza Group LONN:SW	16.74B	284M	2022-06
Merck MRK:GR	€ 48717M	2482M	2022-06
Novartis NOVN:VX	SF 122910M	2308M	2022-06
Novartis NVS:US	$ 122910M	2308M	2022-06
Orion ORNBV:FH	€ 1270.8M	46.1M	2022-06
Recordati REC:IM	€ 3984.1M	341.14M	2022-06
Regeneron Pharmaceuticals REGN:US	$ 27205.8M	857.1M	2022-06

Novartis Des Atouts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2022.